Publications by authors named "Toshio Kinoshita"

Article Synopsis
  • ARNIs are primarily used for heart failure treatment but have limited approval for hypertension in some countries.
  • A study was conducted on 50 hypertensive patients switching to ARNIs, measuring arterial stiffness with the cardio-ankle vascular index (CAVI) before and after treatment.
  • Results showed significant reductions in systolic and diastolic blood pressure, as well as decreased CAVI, suggesting that ARNIs can improve hypertension and reduce heart strain.
View Article and Find Full Text PDF
Article Synopsis
  • Factor Xa inhibitors like rivaroxaban offer a more convenient treatment option for deep vein thrombosis (DVT), but there is limited data on the effectiveness of these treatments after three months.
  • This study compared two groups of patients: one treated with rivaroxaban (group A) and another treated with traditional anticoagulants (group B), analyzing the reduction in clot burden using the quantitative ultrasound thrombosis (QUT) score before and after treatment.
  • Results showed significant improvements in clot volume for both groups, but group A (rivaroxaban) experienced a greater reduction in clot size compared to group B, demonstrating the effectiveness of rivaroxaban in treating DVT.
View Article and Find Full Text PDF

Catheter ablation (CA) of atrial fibrillation (AF) triggers, including non-pulmonary vein (PV) foci, contributes to improved procedural outcomes. However, the clinical significance of an AF trigger ablation during second CA procedures for nonparoxysmal AF is unknown. We enrolled 94 patients with nonparoxysmal AF undergoing a second CA.

View Article and Find Full Text PDF

Non-bacterial thrombotic endocarditis (NBTE) is a condition that results in the development of vegetation on cardiac valves that are devoid of inflammation and bacteria. We herein report a 60-year-old man who transferred to our hospital because of a systemic embolism and heart failure. A mass in the right atrium and vegetation on the mitral valve were observed.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic inflammatory rheumatic diseases are linked to premature birth, accelerated atherosclerosis, and an increased risk of cardiovascular disease (CVD).
  • An observational study evaluated the impact of glucocorticoid (GC) therapy on arterial stiffness in 28 patients, noting that arterial stiffness increased after 3 months of treatment but returned to baseline after 6 months, particularly in younger patients.
  • The study suggests that younger patients may experience improved arterial stiffness due to reduced inflammation from GC therapy, and that the lymphocyte-to-monocyte ratio (LMR) before treatment could help predict changes in stiffness.
View Article and Find Full Text PDF

Obesity-induced heart failure (HF) in young people is a serious problem. The treatments for HF have developed in recent years. The following four basic HF drugs have been widely recognized as the "Fantastic Four": beta-adrenergic blocking agents, mineralocorticoid receptor antagonists (MRA), sodium glucose transporter 2 inhibitors (SGLT2 inhibitors), and angiotensin receptor neprilysin inhibitors (ARNI).

View Article and Find Full Text PDF

A 72-year-old man presented to our clinic with hypertension. Arterial stiffness evaluated by cardio ankle vascular index (CAVI) was markedly increased at 13.5.

View Article and Find Full Text PDF

Background: It has been reported that early detection and treatment of cancer therapy- related cardiac dysfunction (CTRCD) improves its prognosis. The detailed relationships between electrocardiographic repolarization indices and decreased left ventricular function in CTRCD have not been elucidated. We closely assessed such relationships in patients with doxorubicin (DOX)-induced CTRCD.

View Article and Find Full Text PDF

Background: The mitral L-wave, a prominent mid-diastolic filling wave in echocardiographic examinations, is associated with severe left ventricular diastolic dysfunction. The relationship between the mitral L-wave and outcome of catheter ablation (CA) in patients with atrial fibrillation (AF) has not been established. This study aimed to evaluate the predictive value of mitral L-waves on AF recurrence after CA.

View Article and Find Full Text PDF

Hypertension increases arterial stiffness, leading to dysfunction and structural changes in the left atrium (LA) and left ventricle (LV). However, the effects of hypertension on the right atrium (RA) and the right ventricle are still not fully understood. The purpose of this study was to clarify whether there is an interaction not only in the left ventricular system but also in the right ventricular system in hypertensive patients with preserved LV ejection fraction.

View Article and Find Full Text PDF

Background: The inducibility of atrial fibrillation (AF) and incidence of nonpulmonary vein (nonPV) triggers in patients with heart failure (HF) have not been elucidated. Furthermore, the relationship between AF triggers and the change in the left ventricular (LV) function after catheter ablation (CA) remains unclear.

Methods: A total of 101 consecutive patients with a history of HF due to tachycardia who underwent CA of AF were prospectively enrolled (64.

View Article and Find Full Text PDF
Article Synopsis
  • Noninvasive electrocardiographic markers (NIEMs) show potential in predicting sudden cardiac death risk, especially in patients with chronic kidney disease (CKD) and organic heart disease.
  • A study of 183 CKD-SHD patients revealed that the presence of late potentials (w-LPs) and nonsustained ventricular tachycardia (NSVT) significantly increased the risk of lethal cardiac events during a follow-up of about 24 months.
  • While w-LPs and NSVT were effective indicators of serious heart issues, other NIEMs did not predict heart-related hospital admissions, although there was a link between left ventricular mass index and hospital visits.
View Article and Find Full Text PDF

Background: The predictive value of the cardio-ankle vascular index (CAVI) for estimating the efficacy outcome of catheter ablation (CA) in atrial fibrillation (AF) patients is unclear. We aimed to examine the predictive performance of the CAVI for recurrences of atrial arrhythmias after CA.

Methods: We enrolled a total of 193 patients with AF (paroxysmal 126 and non-paroxysmal 67) who underwent initial CA procedures at our institute, and CAVI measurements were conducted between January 2016 and March 2017.

View Article and Find Full Text PDF

Intracardiac defibrillation (IDF) is performed to restore sinus rhythm (SR) during radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF). This study aimed to investigate the change in the IDF threshold before and after RFCA during the ablation procedure and determine whether the IDF threshold after RFCA was associated with the AF substrate and AF recurrence. A total of 141 consecutive patients with drug-refractory persistent AF (age 62.

View Article and Find Full Text PDF

Background: Malnutrition has been reported to be associated with worse clinical outcomes in various cardiovascular diseases. We aimed to investigate the clinical significance of the nutritional status in atrial fibrillation (AF) patients aged 80 years and over receiving oral anticoagulants (OACs), focusing on the difference between direct OACs (DOACs) and warfarin treatment.

Methods: This was a retrospective and observational study.

View Article and Find Full Text PDF

Background: Dealing with chemotherapy-related cardiac dysfunction (CTRCD) remains a significant problem complicated by the difficulty in early detection of cardiotoxicity. Electrocardiogram (ECG) is expected to be the most realistic methodology due to lower cost-performance and non-invasiveness. We investigated the long-term visual fluctuations in the ECG waveforms in patients with chronic doxorubicin (DOX)-induced cardiotoxicity to identify ECG indices for the early detection of cardiotoxicity.

View Article and Find Full Text PDF

Background: Noninvasive electrocardiographic (ECG) markers are promising arrhythmic risk stratification tools for identifying sudden cardiac death. However, little is known about the usefulness of noninvasive ECG markers derived from ambulatory ECGs (AECG) in patients with previous myocardial infarction (pMI). We aimed to determine whether the ECG markers derived from AECG can predict serious cardiac events in patients with pMI.

View Article and Find Full Text PDF

Clinical experience with landiolol use in patients with atrial fibrillation (AF) and a severely depressed left ventricular (LV) function is limited. We compared the efficacy and safety of landiolol with that of digoxin as an intravenous drug in controlling the heart rate (HR) during AF associated with a very low LV ejection fraction (LVEF).We retrospectively analyzed 53 patients treated with landiolol (n = 34) or digoxin (n = 19) for AF tachycardias with an LVEF ≤ 25.

View Article and Find Full Text PDF

The transdermal bisoprolol patch (TB) was designed to maintain a sustained concentration of bisoprolol in plasma by a higher trough concentration than oral bisoporolol (OB). We compared the efficacy between TB and OB in patients with idiopathic premature ventricular contractions (PVCs) while considering their duration of action.A total of 78 patients with a PVC count of ≥ 3,000 beats/24 hours were divided into groups treated with TB 4 mg (n = 43) or OB 2.

View Article and Find Full Text PDF

Catheter ablation is currently an established treatment for symptomatic paroxysmal atrial fibrillation (AF). We focused on elderly patients with a high prevalence of AF and attempted to identify the clinical factors associated with unsuccessful ablation outcomes.Among 735 consecutive patients who underwent AF ablation procedures, 108 (14.

View Article and Find Full Text PDF

Indoxyl sulfate (IS), a protein-bound uremic toxin, induces chronic kidney disease (CKD) and atrial fibrillation (AF). Catheter ablation (CA) of AF improves the renal function. However, the transition of uremic toxins is unclear.

View Article and Find Full Text PDF

Background: The safety and efficacy of an oral anticoagulant (OAC) treatment and the difference between direct OACs (DOACs) and warfarin in nonsevere frail elderly patients with AF are unclear.

Methods: This was a retrospective and observational study of 354 patients over 80 years of age with nonsevere frailty who were diagnosed with AF and treated with OACs. Nonsevere frailty was defined as a clinical frailty scale score of <7.

View Article and Find Full Text PDF